BJU International

Article	Citations
Is Artificial Intelligence Ready for “Primetime” in Urology?	87
Journal information	74
Editorial Board	62
April's reviewers of the month	57
Editorial Board	50
Eve's and Adam's rib for prostate cancer screening	46
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	43
	43
The European Association of Urology talent incubator: bridging competencies for holistic urological care	42
	42
Author Index	41
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	40
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	39
Recent key papers in prostate cancer	38
MRI, Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	38
April's reviewers of the month	37
Lower urinary tract electrical sensory assessment: a systematic review and meta‐analysis	35
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	35
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	33
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality	32
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	32
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	31
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	31
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	31
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	28

Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	28
Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	25
The LANDMARK project: providing summaries of key papers that have shaped urological practice	25
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	24
Response to Chen et al.	24
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of pros	24
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	24
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	23
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	23
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	23
Building a research profile during residency	23
September's reviewers of the month	23
Learning curve analysis of single‐port robot‐assisted extraperitoneal prostatectomy using the cumulative sum (CUSUM) method	21
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	21
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	21
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	21
September's reviewers of the month	21
	20
Table of Contents	20
Editorial Board	20
Progress in the management of stone disease	20
	19
Thulium fibre laser lithotripsy, the new standard?	19
Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?	19
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	19
Caval thrombectomy a urological leap into the unknown – a call for action	19
	19
Can exercise increase natural killer cell infiltration of the prostate?	18
Sustainability in urology – are we doing enough?	18
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	18
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway	18
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.	18
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	18
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	17
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	17
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	17
Corrigendum	17
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	17
Can only AI save us from the burden of administration?	17
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	16
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	16
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	16
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	16
Is Gleason 6 cancer? The answer is more than just a ‘name’	16
Preferences between three options for androgen deprivation therapy: a focus group study	16
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	16
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	16
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	16
August's reviewers of the month	16
The effect of different assays on prostate‐specific antigen testing	16

Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	16
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	16
Issue Information	15
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	15
Editorial Board	15
Journal information	15
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates	15
Re‐defining the interpretation of 24‐h urine studies for stone formers	15
Journal information	15
	14
Issue Information	14
Editorial Board	14
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy	14
Editorial Board	14
	14
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	13
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	13
Development of an optically transparent kidney model for laser lithotripsy research	13
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	13
Clinical presentation of bacille Calmette–Guérin (BCG) infections after BCG instillation therapy	13
Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser	13
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	13
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	13
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	13
Cystectomy and lymphadenectomy – we now node how far to go!	13
Response to Zhu et al.	13
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	13
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	13
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of	12
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	12
	12
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	12
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’	12
Key ingredients for running a randomised controlled trial in a surgical day unit	12
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	12
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	12
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy	12
‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis	12
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	11
Table of Contents	11
Acute Urinary Retention and Cancer; Is It All About the Prostate?	11
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	11
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	11
There is more to disposable endoscopes than whether they work…	11
Perspectives on technology: Single‐use catheters – evidence and environmental impact	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Issue Information	11
Neural monitoring of central responses to lower urinary tract function	11
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	11
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	11
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	11
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	11
The importance of the urologist in male oncology fertility preservation	11
Table of Contents	11
Global Urology, Urolink, and the BJUI	11
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	11
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	10
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	10
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	10
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer	10
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	10
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	10
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	10
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE‐IMMUNO study	10
Emergency department visits for radiation cystitis among patients with a prostate cancer history	10
Stone volume instead of maximum stone diameter: results from an international survey	10
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	10
Recommendation on the use of protective eyewear in endourological laser procedures	10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	10
First‐line programmed death receptor‐1 (PD‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cance	10
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	10
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	10
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	10
Editorial Board	9
Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation	9
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer	9
June's reviewers of the month	9
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes	9
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	9

	9
Editorial Board	9
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	9
August's reviewers of the month	9
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	9
Systematic review of PSA reference intervals in the gender diverse population with prostates	9
A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys	9
Editorial Board	9
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	9
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	9
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’	9
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system	9
January’s reviewers of the month	9
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study	9
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	8
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	8
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder	8
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study	8
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	8
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID‐19	8
The first step in shared decision‐making for prostate cancer screening	8
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	8
Issue Information	8
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer	8
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	8
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	8
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers	8
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency	8
Journal information	8
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	8
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset	8
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	8
Keith Kirkland Presentation	7
Villis Marshall Presentation	7
	7
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’	7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	7
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses	7
Journal information	7
Bladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	7
Molecular margin status after radical prostatectomy using glutathione S‐transferase P1 (GSTP1) promoter hypermethylation	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	7
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	7
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	7
	7
Concurrent Session Presentations	7
Abstract	7
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care	7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	7
Table of Contents	6
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	6
Reply to Huseyin Besiroglu's Letter to the Editor regarding the article ‘Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?’	6
Voiding and renal function 10 years after radical cystectomy and orthotopic neobladder in women	6
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	6
Continence criteria of 193 618 patients after open, laparoscopic, and robot‐assisted radical prostatectomy	6
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney	6
Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study	6
Response to Brönimann et al. 'The Challenges of Conducting a Surgical Trial – Reflections on the EBRUC II Trial'	6
Journal information	6
Issue Information	6
Conservative management in high‐grade renal trauma: a systematic review and meta‐analysis	6
Depictions of penises in historical paintings reflect changing perceptions of the ideal penis size	6
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics	6
Accuracy of cognitive vs software‐guided MRI‐targeted biopsy in predicting final grading at prostatectomy	6
Electronic medical records – a disappointing mirage for clinicians and research	6
A systematic review on the outcomes of local anaesthetic transperineal prostate biopsy	6
Response to Tang et al. ‘Evaluating the efficacy of physiotherapy in post‐prostatectomy continence and pelvic muscle function’	6
Reply to ‘Letter Re: Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction’	6
EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases	6
	6
	6
Table of Contents	6
Is genetic testing coming of age in advanced prostate cancer?	6
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis	6
Is there any difference between cognitive and fusion transrectal biopsies if performed by residents?	6
Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft	6
	6
Response to Takahashi	6
Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience	6
Journal information	6